Orexigen Therapeutics Inc (NASDAQ:OREX)

6.67
Delayed Data
As of May 01
 +0.10 / +1.52%
Today’s Change
3.11
Today|||52-Week Range
9.37
+10.07%
Year-to-Date

Today’s Trading

Previous close6.57
Today’s open6.63
Day’s range6.50 - 6.83
Volume1,859,196
Average volume (3 months)5,452,205
Market cap$833.7M
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-108.04%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book36.85

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.81+4.56%
EGRXEagle Pharmaceutical...+2.78+5.28%
ZFGNZafgen Inc+1.00+3.21%
COCPCocrystal Pharma Inc+0.02+1.71%
Data as of 4:00pm ET, 05/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers